Journal profile · Medicine
Chemical & Biomedical Imaging
ISSN 2832-3637 · American Chemical Society · UNITED STATES · Founded 2023
Chemical & Biomedical Imaging: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 6.7 (journal website); fully open access; APC about USD 3,500; median 59 days to acceptance (121 articles, last 24 months); 176 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Chemical & Biomedical Imaging is published by American Chemical Society and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Nanoplatforms for cancer theranostics, Advanced biosensing and bioanalysis techniques and Advanced Fluorescence Microscopy Techniques, together about 28.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Chemical & Biomedical Imaging is a peer-reviewed open access journal devoted to the publication of cutting-edge research papers on all aspects of chemical and biomedical imaging. This interdisciplinary field sits at the intersection of chemistry, physics, biology, materials, engineering, and medicine. The journal aims to bring together researchers from across these disciplines to address cutting-edge challenges of fundamental research and applications. Chemical & Biomedical Imaging welcomes papers that: showcase innovations in molecular and biomedical imaging push the limits of chemical, spatial and temporal resolution at single molecule, single particle or single cell level demonstrate advances in developing new chemical probes and methodologies for biomedical applications Topics of particular interest include, but are not limited to: Imaging of processes and reactions Imaging of nanoscale, microscale, and mesoscale materials Imaging of biological interactions and interfaces Single-molecule and cellular imaging Whole-organ and whole-body imaging Molecular imaging probes and contrast agents Bioluminescence, chemiluminescence and electrochemiluminescence imaging Nanophotonics and imaging Chemical tools for new imaging modalities Chemical and imaging techniques in diagnosis and therapy Imaging-guided drug delivery AI and machine learning assisted imaging
From the journal's Aims & Scope
Editor-in-chief Zijian GuoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoplatforms for cancer theranosticsEngineering11.7%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology9.2%
- Advanced Fluorescence Microscopy TechniquesBiochemistry, Genetics and Molecular Biology7.2%
- Molecular Sensors and Ion DetectionChemistry5.9%
- Electrochemical Analysis and ApplicationsChemistry5.4%
- Spectroscopy Techniques in Biomedical and Chemical ResearchBiochemistry, Genetics and Molecular Biology5.3%
- Luminescence and Fluorescent MaterialsMaterials Science4.7%
- Photoacoustic and Ultrasonic ImagingEngineering3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Analytical | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6.7Publisher website ·
- 5-year impact factor (publisher)
- 6.7Publisher website ·
- CiteScore 2026-06
- 7.4LetPub ·
- CiteScore (publisher)
- 7.4Publisher website ·
- SJR 2026-06
- 1.35LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 117OpenAlex ·
- 2-year mean citedness
- 3.68OpenAlex ·
- Self-citation rate
- 10.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 140LetPub ·
- Downloads per year (publisher)
- 257,952Publisher website ·
Articles by year OpenAlex count · 570 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 184 | 184 | 138 |
| 2025 | 176 | 176 | 682 |
| 2024 | 99 | 99 | 868 |
| 2023 | 111 | 111 | 1,902 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
59 daysMedian, submission to acceptance · P25–P75 43 days – 80 days
- Acceptance to online
- median 10 days (121 articles)
- Submission to online
- median 70 days
- Sample
- 121 articles with submission and acceptance dates (283 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- First decision after review
- 24.9 daysPublisher website ·
- Submission to acceptance
- 60 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,500 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 0 / EUR 0 / GBP 0 / JPY 0 / CHF 0 / CAD 0 / AUD 0 | — | — | |
| LetPub | USD 3,500 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Chemical Society
- Country or region
- UNITED STATES
- Language
- English
- Founded
- 2023
- ISSN
- 2832-3637
- Society / sponsor
- Nanjing University
- Latest issue on the website
- Volume 4, Issue 8 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Chemical & Biomedical Imaging
What CAS zone is Chemical & Biomedical Imaging in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Chemical & Biomedical Imaging?
The journal's website gives an impact factor of 6.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 7.4, h-index 28.
How long does peer review take at Chemical & Biomedical Imaging?
Based on the dates recorded on 121 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 59 days (interquartile range 43–80 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Chemical & Biomedical Imaging?
According to LetPub and DOAJ records, Chemical & Biomedical Imaging is indexed in ESCI, Scopus and DOAJ.
Is Chemical & Biomedical Imaging open access, and what is the APC?
Chemical & Biomedical Imaging is a fully open-access journal. APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .